| Passive Immunotherapy In Patients With SARS CoV-2 (NCT05578391) | Fundacin Biomedica Galicia Sur | 2020-01-01 |
| Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma (NCT05182957) | The First Affiliated Hospital of Soochow University | 2020-01-01 |
| Low Dose IL-2 in the Treatment of Immune-associated ALS Syndrome (NCT04952155) | Peking University Third Hospital | 2020-01-01 |
| The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study. (NCT04342819) | The University of The West Indies | 2020-01-01 |
| The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia (NCT04217148) | Peking University People's Hospital | 2020-01-01 |
| Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal Women (NCT04530916) | Colorado State University | 2020-01-01 |
| LISA vs INSURE in the Treatment of Respiratory Distress Syndrome in Preterm Infants (NCT04126382) | Anhui Provincial Hospital | 2020-01-01 |
| Rhodiola Rosea for Coronary Microvascular Disease (NCT04218916) | Qilu Hospital of Shandong University | 2020-01-01 |
| Clinical Experience of Thalidomide in Thalassemic Patients (NCT05132270) | Children's Hospital Karachi | 2020-01-01 |
| Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB) (NCT04209192) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2020-01-01 |
| Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory Arthritis (NCT04115020) | Brigham and Women's Hospital | 2020-01-01 |
| The Effect of Topical Tranexamic Acid on Postoperative Bleeding From Superficial Wounds (NCT02918201) | St. Olavs Hospital | 2020-01-01 |
| The Additional Role of Supplemental Oxygen Therapy in Accelerated Corneal Collagen Cross-linking in Progressive Keratoconus. A Randomized Clinical Trial (NCT04343326) | Shahid Beheshti University of Medical Sciences | 2020-01-01 |
| Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab (NCT04013854) | Abramson Cancer Center at Penn Medicine | 2020-01-01 |
| Conditioning Electrical Stimulation to Improve Outcomes in Carpal Tunnel Syndrome (NCT04191538) | University of Alberta | 2020-01-01 |
| MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma (NCT04134468) | Abramson Cancer Center at Penn Medicine | 2020-01-01 |
| HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC (NCT05566457) | Chinese Academy of Medical Sciences | 2020-01-01 |
| RIGENERA 2.0 Trial (NCT02502747) | Catholic University of the Sacred Heart | 2020-01-01 |
| Radiotherapy of Head and Neck Cancer Using an Intraoral Stent (NCT04330781) | Oslo University Hospital | 2020-01-01 |
| REPlaCE- Randomized Trial Evaluating the Use of Prothrombin Complex concEntrate to Improve Survival in Patients With Traumatic Coagulopathy (NCT03981484) | Bellal A. Joseph, MD, FACS | 2020-01-01 |
| Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC (NCT04345146) | Sun Yat-sen University | 2020-01-01 |
| A Mechanism Based Proof of Concept Study of the Effects of Duloxetine in the Treatment of Patients With Osteoarthritic Knee Pain (NCT04224584) | Kristian Kjær Petersen | 2020-01-01 |
| Epidural Stimulation After Spinal Cord Injury (NCT04105296) | McGuire Research Institute | 2020-01-01 |
| Low-dose AZA Combined With Short Term CAG Derived Regimen as a Bridging Treatment in Patients With Advanced MDS Prior to Allo-HSCT (NCT04216355) | Fujian Medical University | 2020-01-01 |
| Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction (NCT03041259) | Reven Pharmaceuticals, Inc. | 2020-01-01 |
| Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease (NCT01125449) | Situs Cancer Research Center | 2020-01-01 |
| Brazilian Lung Immunotherapy Study (NCT05081674) | Hospital Israelita Albert Einstein | 2020-01-01 |
| ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI (NCT03829475) | Brigham and Women's Hospital | 2020-01-01 |
| N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV (NCT04144335) | University of Minnesota | 2020-01-01 |
| Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study (NCT04488601) | AgelessRx | 2020-01-01 |
| Vaginal Prolapse Surgery Accompanied by Mid Urethral Sling Versus no Sling for Reduction of Postoperative Incontinence (NCT04251923) | B.P. Koirala Institute of Health Sciences | 2020-01-01 |
| Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML (NCT05404516) | Nanfang Hospital, Southern Medical University | 2020-01-01 |
| Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer (NCT04246502) | Shandong Cancer Hospital and Institute | 2020-01-01 |
| A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) (NCT04129710) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-01-01 |
| RCT of Sepsis Machine Learning Algorithm (NCT03882476) | Dascena | 2020-01-01 |
| Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer. (NCT04265274) | National Cancer Institute, Slovakia | 2020-01-01 |
| A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients (NCT02289300) | A2 Healthcare Taiwan Corporation | 2020-01-01 |
| PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer (NCT05346107) | Xijing Hospital | 2020-01-01 |
| Comparison of the Anaesthetic Gases in Maintainance of General Anaesthesia in Paediatrics (NCT04771962) | Universiti Sains Malaysia | 2020-01-01 |
| DAOIB for the Treatment of Mild Cognitive Impairment (NCT04736355) | Chang Gung Memorial Hospital | 2020-01-01 |
| Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE) (NCT04004702) | Walter Reed National Military Medical Center | 2020-01-01 |
| A Trial of Cardiac Injections of iMP Cells During CABG Surgery (NCT03515291) | Cell Therapy Ltd. | 2020-01-01 |
| Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation (NCT04232722) | Zhejiang University | 2020-01-01 |
| Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) (NCT04202653) | Tongji Hospital | 2020-01-01 |
| Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer (NCT04211896) | The First Affiliated Hospital with Nanjing Medical University | 2020-01-01 |
| Comparing the Consolidation Regimens of IDA With Intermediate-dose Cytarabine Versus Intermediate-dose Cytarabine Alone for Elderly AML Patients (NCT04216771) | Fujian Medical University | 2020-01-01 |
| Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM. (NCT04003792) | Rabin Medical Center | 2020-01-01 |
| Does Terlipressin Improve Renal Outcome After Liver Surgery (NCT02368249) | University of Zurich | 2020-01-01 |
| A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy (NCT04063215) | Hope Biosciences LLC | 2020-01-01 |
| Uric Acid Lowering Trial in Youth Onset T2D (NCT03899883) | University of Colorado, Denver | 2020-01-01 |
| Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (NCT02368587) | Navy General Hospital, Beijing | 2020-01-01 |
| LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615) (NCT04031872) | The Netherlands Cancer Institute | 2020-01-01 |
| Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer (NCT04300959) | Zhejiang Cancer Hospital | 2020-01-01 |
| Tranexamic Acid for the Prevention of Postpartum Haemorrhage (NCT04707950) | Benha University | 2020-01-01 |
| GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies (NCT03214666) | GT Biopharma, Inc. | 2020-01-01 |
| Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer (NCT04572542) | The First Affiliated Hospital of Xiamen University | 2020-01-01 |
| Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC (NCT04241523) | Shanghai Zhongshan Hospital | 2020-01-01 |
| DAOIB Combined With tDCS for Early-phase Dementia (NCT04737096) | Chang Gung Memorial Hospital | 2020-01-01 |
| Camrelizumab Combined With Local Treatment in NSCLC Patients With BM (NCT04291092) | Zhejiang Cancer Hospital | 2020-01-01 |
| Trastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC (NCT04168931) | AC Camargo Cancer Center | 2020-01-01 |
| Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss, a Randomized Controlled Trial (NCT04274608) | Tan Tock Seng Hospital | 2020-01-01 |
| Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer (NCT04165993) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2019-12-31 |
| Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1 (NCT03739996) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-12-31 |
| Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors (NCT03967223) | USWM CT, LLC | 2019-12-31 |
| Investigating the Effect of Herbal Medicine Nasal Irrigation on Treatment of Chronic Rhinitis and Sinusitis (NCT04046393) | Chang Gung Memorial Hospital | 2019-12-31 |
| Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery (NCT02923778) | National Cancer Institute (NCI) | 2019-12-31 |
| Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors (NCT03991832) | University Health Network, Toronto | 2019-12-31 |
| Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects (NCT03721965) | Incyte Corporation | 2019-12-31 |
| Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC (NCT04303130) | Peking University Cancer Hospital & Institute | 2019-12-31 |
| Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (NCT06703346) | USWM CT, LLC | 2019-12-31 |
| A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation) (NCT04229706) | Tasly Pharmaceutical Group Co., Ltd | 2019-12-31 |
| Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia (NCT03374332) | Brown University | 2019-12-31 |
| Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma (NCT05993299) | USWM, LLC (dba US WorldMeds) | 2019-12-31 |
| Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients (NCT04133259) | Henlix, Inc | 2019-12-31 |
| Trial of Maintenance With Niraparib- Uterine Serous Carcinoma (NCT04080284) | Northwell Health | 2019-12-30 |
| Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions (NCT04071756) | Dana-Farber Cancer Institute | 2019-12-30 |
| Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer (NCT04521348) | Fudan University | 2019-12-30 |
| CPX-351 in Patients Treated for Higher-risk Myelodysplastic Syndromes Experiencing Hypomethylating Agent Failure. (NCT04109690) | Yale University | 2019-12-30 |
| Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs (NCT03896503) | National Cancer Institute (NCI) | 2019-12-30 |
| A Single-arm, Phase Ⅱ Clinical Trial of Anlotinib Hydrochloride Combined With Irinotecan or Docetaxel for Second Line Treatment of Nonsensitive Relapsed Small-cell Lung Cancer (NCT04757779) | First People's Hospital of Hangzhou | 2019-12-30 |
| Trastuzumab Biosimilar (Samfenet®) Plus Treatment of Physician's Choice (TPC) in Patients With HER2-positive Solid Tumor (NCT04215159) | Jin-Hee Ahn | 2019-12-30 |
| 11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours (NCT06100367) | Changi General Hospital | 2019-12-30 |
| HMPL-453 in Advanced Malignant Mesothelioma (NCT04290325) | Hutchison Medipharma Limited | 2019-12-30 |
| Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors (NCT04052204) | Pfizer | 2019-12-30 |
| Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. (NCT04065841) | Novartis Pharmaceuticals | 2019-12-30 |
| Niraparib/TTFields in GBM (NCT04221503) | Abramson Cancer Center at Penn Medicine | 2019-12-30 |
| Study of Safety and Proof of the Mechanism of BLZ945 in ALS Patients (NCT04066244) | Novartis Pharmaceuticals | 2019-12-30 |
| Cardiac Changes in Early Parkinson's Disease: A Follow up Study (NCT04218968) | Cedars-Sinai Medical Center | 2019-12-30 |
| Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis (NCT04307862) | Shulov Innovate for Science Ltd. 2012 | 2019-12-29 |
| Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer (NCT04194684) | Chinese Academy of Medical Sciences | 2019-12-28 |
| TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study (NCT04109924) | Roswell Park Cancer Institute | 2019-12-27 |
| Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor (NCT04174677) | Amgen | 2019-12-27 |
| Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia (NCT04251910) | BioXcel Therapeutics Inc | 2019-12-27 |
| Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age (NCT04358731) | Serum Institute of India Pvt. Ltd. | 2019-12-27 |
| Propranolol in Angiosarcoma (NCT04518124) | The Netherlands Cancer Institute | 2019-12-27 |
| NGS as the First-line Treatment in Advanced Biliary Tract Cancer (NCT04172402) | National Health Research Institutes, Taiwan | 2019-12-27 |
| An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) (NCT04145531) | Jazz Pharmaceuticals | 2019-12-27 |
| Prostate SABR With Intra-Prostatic SABR Boost (NCT04212715) | King Saud University | 2019-12-26 |
| High-Risk Skin Cancers With Atezolizumab Plus NT-I7 (NCT03901573) | NeoImmuneTech | 2019-12-26 |
| Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia (NCT04230239) | PETHEMA Foundation | 2019-12-26 |